NCT05816070

Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Bacterial Conjunctivitis

A Phase II, Multi-Center, Randomized, Parallel Controlled Study to Evaluate the Clinical Efficacy and Safety of IVIEW 1201 Compared to Ofloxacin Eye Drops in the Treatment of Acute Bacterial Conjunctivitis

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 129 (actual)
• Sponsor: IVIEW Therapeutics Inc. · Industry
• Sex: All
• Age: 15 Years
• Healthy volunteers: Not accepted

Summary

A Phase 2, Multi-center, Randomized, Parallel Controlled Study to Evaluate the Clinical Efficacy and Safety of IVIEW-1201 (1.0% Povidone-Iodine) Gel Forming Ophthalmic Solution Compared to Ofloxacin Eye Drops in the Treatment of Acute Bacterial Conjunctivitis

Conditions

• Acute Bacterial Conjunctivitis

Interventions

Type	Name	Description
DRUG	IVIEW-1201	Four times per day for day 1-2 and three times per day for day 3-7
DRUG	Ofloxacin Eye Drops	Four times per day for day 1-2 and three times per day for day 3-7

Timeline

• Start date: 2023-01-05
• Primary completion: 2023-11-13
• Completion: 2024-10-12
• First posted: 2023-04-18
• Last updated: 2025-12-02
• Results posted: 2025-06-15

Locations

1 site across 1 country: China

Regulatory

• FDA-regulated drug study